Financials
- Market Capitalization 8.54 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.21
市销率
16.08
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 995 | ABVX Abivax SA - American Depositary Shares | 113.37 USD | -0.81% | -1.37% | -9.23% | +38.26% | 8.90 B USD | ||
| 1009 | IMVT Immunovant, Inc. - Common Stock | 41.19 USD | -6.00% | -7.17% | +5.67% | +114.42% | 8.51 B USD | ||
| 1022 | APGE Apogee Therapeutics, Inc. - Common Stock | 134.97 USD | +0.01% | +0.16% | +0.61% | +151.86% | 8.40 B USD | ||
| 1031 | TGTX TG Therapeutics, Inc. - Common Stock | 53.92 USD | -3.23% | -0.64% | -1.73% | +85.80% | 8.25 B USD |